All Companies
Ticker CDTX
This stock is no longer actively trading
You reached the page — here's exactly what CDTX is, and why it's out of scope for now.
What this ticker is
CDTX
Cidara Therapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $5.6B
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for th…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted